CL2024002831A1 - Composicion acuosa. - Google Patents

Composicion acuosa.

Info

Publication number
CL2024002831A1
CL2024002831A1 CL2024002831A CL2024002831A CL2024002831A1 CL 2024002831 A1 CL2024002831 A1 CL 2024002831A1 CL 2024002831 A CL2024002831 A CL 2024002831A CL 2024002831 A CL2024002831 A CL 2024002831A CL 2024002831 A1 CL2024002831 A1 CL 2024002831A1
Authority
CL
Chile
Prior art keywords
aqueous composition
esters
acceptable salts
pharmacologically acceptable
relates
Prior art date
Application number
CL2024002831A
Other languages
English (en)
Spanish (es)
Inventor
ORITANI Rika
KITANI Chise
NISHIMOTO Akinori
Original Assignee
Tsubota Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Lab Inc filed Critical Tsubota Lab Inc
Publication of CL2024002831A1 publication Critical patent/CL2024002831A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CL2024002831A 2022-03-25 2024-09-23 Composicion acuosa. CL2024002831A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022050275 2022-03-25

Publications (1)

Publication Number Publication Date
CL2024002831A1 true CL2024002831A1 (es) 2025-01-24

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2024002831A CL2024002831A1 (es) 2022-03-25 2024-09-23 Composicion acuosa.

Country Status (14)

Country Link
US (1) US20250213510A1 (https=)
EP (1) EP4483867A1 (https=)
JP (1) JPWO2023182480A1 (https=)
KR (1) KR20240159636A (https=)
CN (1) CN118973561A (https=)
AU (1) AU2023240729A1 (https=)
CA (1) CA3254664A1 (https=)
CL (1) CL2024002831A1 (https=)
IL (1) IL315871A (https=)
MA (1) MA67594B1 (https=)
MX (1) MX2024011634A (https=)
PE (1) PE20250746A1 (https=)
TW (1) TW202400133A (https=)
WO (1) WO2023182480A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
WO2018164113A1 (ja) * 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2018181294A1 (ja) * 2017-03-27 2018-10-04 興和株式会社 医薬製剤
JP7474706B2 (ja) 2018-12-18 2024-04-25 参天製薬株式会社 ４－フェニル酪酸を含有する老視の治療または予防剤

Also Published As

Publication number Publication date
TW202400133A (zh) 2024-01-01
US20250213510A1 (en) 2025-07-03
CN118973561A (zh) 2024-11-15
IL315871A (en) 2024-11-01
CA3254664A1 (en) 2025-07-03
PE20250746A1 (es) 2025-03-13
MA67594A1 (fr) 2025-07-31
JPWO2023182480A1 (https=) 2023-09-28
MA67594B1 (fr) 2026-01-30
WO2023182480A1 (ja) 2023-09-28
EP4483867A1 (en) 2025-01-01
AU2023240729A1 (en) 2024-10-03
KR20240159636A (ko) 2024-11-05
MX2024011634A (es) 2024-09-30

Similar Documents

Publication Publication Date Title
PY2117017A (es) Ácido sulfúrico modificado y usos del mismo
ECSP22075396A (es) Ácido sulfúrico modificado y sus usos
AR108591A1 (es) Composición acuosa que contiene atropina
CL2020002252A1 (es) Formulación oftálmica.
CL2009001580A1 (es) Composicion oxidante que comprende 20ppm de dioxido de cloro, aniones oxicloro; y un segiundo agente oxidante que es un peroxido; donde la composicion comprende no mas de 0,25mg de aniones oxi-cloro por gramo de composicion.
CL2021003532A1 (es) Método para estabilizar el ph de una composición acuosa que comprende un fármaco.
CL2024002831A1 (es) Composicion acuosa.
UY38345A (es) Composición farmacéutica que comprende agente antiplaquetario e inhibidor de la secreción de ácido g
MX2024006597A (es) Composiciones solidas disolubles.
MX2023013617A (es) Composicion monomerica, composicion de resina metacrilica y cuerpo moldeado de resina.
CR7730A (es) Composiciones antimicrobianas sinergeticas, con bajo contenido de formaldehido libre, estables de donadores de aldehido y acido dehidroacetico
BR112018067539A2 (pt) processo para a separação de vanádio na forma de óxido de vanádio, óxido de ferro-vanádio, ou ferro-vanádio de soluções contendo tanto ferro dissolvido quanto vanádio dissolvido
PE20090524A1 (es) Composicion farmaceutica que comprende la combinacion de una triazolobenzodiazepina y un agente inhibidor selectivo de la recaptura de serotonina
AR051145A1 (es) Composiciones analgesicas / antipireticas para absorcion potenciada
MX2024009526A (es) Formulación líquida que comprende una proteína de fusión que incluye a-galactosidasa a
WO2010062205A4 (en) Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol
PY2279976A (es) Composición que contiene cariofileno
MX2024006097A (es) Composiciones solidas disolubles.
PE20231661A1 (es) Derivados de acido ursolico sinteticos y metodos de uso de los mismos
MX2021003375A (es) Composiciones de rutina.
AR110905A1 (es) Método de blanqueo de una pasta de papel
CR20240262A (es) Potenciador de perácido
PE20252565A1 (es) Jeringa adecuada para solucion de peroxido de hidrogeno y kit de la misma
AR128779A1 (es) Composición agroquímica en suspensión acuosa
GB632927A (en) The stabilisation of polythionic acid and polythionate solutions